Fig. 3.
Overall survival (A) and PFS (B) curves of patients with intermediate- and high-grade non-Hodgkin’s lymphoma. Highnm23-H1 (≥14.39 ng/mL) patients (n = 105) had a worse prognosis than low nm23-H1 (<14.39 ng/mL) patients (n = 44).
Overall survival (A) and PFS (B) curves of patients with intermediate- and high-grade non-Hodgkin’s lymphoma. Highnm23-H1 (≥14.39 ng/mL) patients (n = 105) had a worse prognosis than low nm23-H1 (<14.39 ng/mL) patients (n = 44).
